Business
ATL1102 for MS FDA Response to Phase IIb Study Plans
ATL1102 for MS FDA Response to Phase IIb Study Plans
About this update from Percheron Therapeutics Limited
[{"type":"text","content":"Percheron Therapeutics Limited has released a press release. View Attachment","length":252,"tagName":"div"}]